Browsing Tag
ASX
164 posts
Why ASX retail investors are watching Ventia (ASX: VNT) bounce after April pullback
Ventia holds $22.1bn work in hand and a $250m buyback. The ACCC trial sits in 2027. Retail investors own half the register and August earnings is the next test.
Telix Pharmaceuticals (TLX) gains European review momentum for TLX101-Px brain cancer imaging candidate
Telix has a glioma imaging gap to fill. Europe’s TLX101-Px review could test whether radiopharma can move beyond prostate cancer.
South32 (S32) reveals $1.1bn Hermosa Taylor capex blowout, but stretches mine life to 33 years as zinc, silver upside grows
South32's Hermosa capex jumped US$1.1B on US tariffs and shaft delays. A 33-year mine life and US$4.5B spot NPV ask whether the market is pricing it right.
Hydrocarbon Dynamics faces funding test as ASX:HCD moves from oilfield chemicals to Canadian minerals
Hydrocarbon Dynamics has cash pressure and a minerals reset. Great Bear could relaunch ASX:HCD, but the raise must land first.
Critical Metals Corp (NASDAQ: CRML) to acquire European Lithium in $835m rare earth play
Critical Metals Corp is paying $835M to buy its own 34% shareholder. The real prize is uncontested control of Greenland's Tanbreez rare earth deposit.
GenusPlus (ASX: GNP) wins Koolunga BESS contract as Australia’s grid storage buildout accelerates
Find out how GenusPlus Group’s $110m Koolunga BESS contract strengthens its role in Australia’s clean energy infrastructure buildout.
Santos (ASX: STO) posts $1.27bn in Q1 revenue as Pikka hits mechanical completion and Barossa readies LNG ramp-up
Santos Q1 2026: $1.27B revenue, Pikka near first oil, Barossa resuming. Quokka appraisal confirms Alaska upside. Full analysis for investors. Read more.
The CEO Minrex Resources (ASX: MRR) needed: Why Max Piirto’s Balkan experience matters more than his job title
Minrex Resources (ASX: MRR) names Max Piirto CEO post-Electrum merger to advance Serbia's Tlamino gold project. Read the full strategic analysis here.
Invion (ASX: IVX) just unlocked the door to 80% of skin cancers — here is what the data shows so far
Invion Limited (ASX: IVX) advances INV043 into basal cell carcinoma after second positive SCC data set. Read what this means for the trial and the company. →
Can American Uranium (ASX: AMU) turn Lo Herma into a more credible Wyoming ISR growth story?
American Uranium Ltd. has expanded Lo Herma in Wyoming. Read why this ISR land move could matter for resource growth, drilling momentum, and market sentiment.